Homocysteine (HCY) antibody and antigen (hapten, BSA/OVA conjugated)
Diagnostic anti-Homocysteine (HCY) antibodies (anti-Homocysteine, anti-HCY) and diagnostic hapten-carrier conjugates BSA-Homocysteine (HCY), OVA-Homocysteine (HCY), KLH-Homocysteine (HCY) antigens for Cardiovascular disease HCY detection in ELISA test, competitive ELISA, Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT.
Go to Neurodegenerative diseases diagnostics products collection >>
Product information
Catalog No. | Description | US $ Price (per mg) |
---|---|---|
GMP-SMT-HCY-Ag01 | BSA-Homocysteine (HCY) | 756 |
GMP-SMT-HCY-Ag02 | OVA-Homocysteine (HCY) | 756 |
GMP-SMT-HCY-Ab01 | Anti-human Homocysteine (HCY) mouse monoclonal antibody (mAb) | 1953 |
GMP-SMT-HCY-Ab02 | Anti-human Homocysteine (HCY) human monoclonal antibody (mAb) | 1953 |
Size: 1mg | 10mg | 100mg
Product Description
Cat No. of Products | GMP-SMT-HCY-Ag01 |
Product Name | BSA-Homocysteine (HCY) |
Target/Biomarker | Homocysteine(HCY) |
Expression platform | Synthetic |
Bioactivity validation | Homocysteine (HCY) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in HCY level test of Cardiovascular disease (dementia, heart disease and stroke.) and related syndrome evaluation. |
Products description | Competitive immunoassay-validated hapten-carrier conjugates BSA-Homocysteine (HCY) / OVA-Homocysteine (HCY) is Synthetic. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Competitive immunoassay validation (Competitive ELISA), ELISA, Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and immunonephelometry. |
Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-SMT-HCY-Ag02 |
Product Name | OVA-Homocysteine (HCY) |
Target/Biomarker | Homocysteine(HCY) |
Expression platform | Synthetic |
Bioactivity validation | Homocysteine (HCY) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in HCY level test of Cardiovascular disease (dementia, heart disease and stroke.) and related syndrome evaluation. |
Products description | Competitive immunoassay-validated hapten-carrier conjugates BSA-Homocysteine (HCY) / OVA-Homocysteine (HCY) is Synthetic. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Competitive immunoassay validation (Competitive ELISA), ELISA, Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and immunonephelometry. |
Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-SMT-HCY-Ab01 |
Product Name | Anti-human Homocysteine (HCY) mouse monoclonal antibody (mAb) |
Target/Biomarker | Homocysteine(HCY) |
Expression platform | CHO |
Isotypes | Mouse IgG |
Bioactivity validation | Human Homocysteine (HCY) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Homocysteine (HCY) antibodies in HCY level test of Cardiovascular disease (dementia, heart disease and stroke.) and related syndrome evaluation. |
Tag | mFc |
Products description | Anti-human Homocysteine (HCY) monoclonal antibody (mAb) is a monoclonal antibody produced by hybridoma technology. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Competitive immunoassay validation (Competitive ELISA),Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and immunonephelometry. |
Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-SMT-HCY-Ab02 |
Product Name | Anti-human Homocysteine (HCY) human monoclonal antibody (mAb) |
Target/Biomarker | Homocysteine(HCY) |
Expression platform | CHO |
Isotypes | Human IgG1 |
Bioactivity validation | Human Homocysteine (HCY) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Homocysteine (HCY) antibodies in HCY level test of Cardiovascular disease (dementia, heart disease and stroke.) and related syndrome evaluation. |
Tag | mFc |
Products description | Anti-human Homocysteine (HCY) monoclonal antibody (mAb) is a monoclonal antibody produced by hybridoma technology. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Competitive immunoassay validation (Competitive ELISA),Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and immunonephelometry. |
Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Target/Biomarker information
Homocysteine is an amino acid. Vitamins B12, B6 and folate break down homocysteine to create other chemicals your body needs. High homocysteine levels may mean you have a vitamin deficiency. Without treatment, elevated homocysteine increases your risks for dementia, heart disease and stroke.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.
Comments
No comments yet.